China
Africa
Explore chapters and articles related to this topic
Klippel−Trenaunay Syndrome
Published in Dongyou Liu, Handbook of Tumor Syndromes, 2020
Sclerotherapy eliminates the pain and discomfort of varicose veins and prevents complications such as venous hemorrhage and ulceration, through injection of a solution directly into the varicose veins to make them collapse and disappear. A variant of sclerotherapy involves injection of a foaming agent mixed with a sclerosing agent under ultrasound guidance. After the foaming agent moves blood out of the vein, the sclerosing agent has better contact with the vein wall.
Catalog of Herbs
Published in James A. Duke, Handbook of Medicinal Herbs, 2018
Bark used for washing clothes in South America, contains circa 10% saponin; used in manufacture of commercial saponins; used in mineral water industry, shampoo liquids, etc. as a foaming agent.20 Has been suggested as a substitute for senega and sarsaparilla. Used in mouthwash, shampoos, and toothpowders.33 As a shampoo — 1 part bergamot, 5 parts powdered quillaja, and 20 parts alcohol, has been recommended to promote the growth of hair. Also, used extensively as a foaming agent in cocktail mixes and root beers. Highest maximum use level averages around 0.01% for such beverages. Also, reported in baked goods, candy, frozen dairy desserts, gelatins, and puddings.29
Allergic contact dermatitis of the vulva
Published in Miranda A. Farage, Howard I. Maibach, The Vulva, 2017
Both ICD and ACD result from the exposure of vulnerable skin to an external agent, and the list of potential allergens is even longer than the lengthy list of known vulvar irritants (see Table 29.1) (5–20). With such a large number of suspects, identifying the responsible agent in ACD can be a difficult task to tackle. Allergens can be found in certain types of creams, detergents, soaps, wipes, perfumes, or other commonly used products. Topical remedies are a prominent source of vulvar ACD, and major culprits include topical anesthetics (e.g., benzocaine), corticosteroids, antibiotics (e.g., neomycin), and herbal extracts (21,22). Reaction to a topical medicament does not necessarily indicate allergy to the product’s active ingredient, as sometimes allergens might unknowingly be part of preservative systems or other inactive components. Examples of such unnoticed offenders include foaming agents such as sodium lauryl sulfate, parabens found in topical antibiotics, and the stabilizer, ethylenediamine, previously used in antifungal creams of the 1970s and 1980s. Scents like “fragrance mix” and balsam of Peru have also been incriminated as inducers of ACD (23).
The preparation, characterization, and application of porous core–shell composite particles produced with laboratory-scale spray dryer
Published in Drug Development and Industrial Pharmacy, 2023
Zhe Li, Lin Zhu, Fu-Cai Chen, Yong-Mei Guan, Li-Hua Chen, Ji-Wen Zhang, Zhi-Xuan Mao, Liang-Shan Ming, Wei-Feng Zhu
The common co-processing methods for preparing PCPs include using porous carrier materials, template agents, and pore-foaming agents [11]. But the drug loading of porous carrier materials is commonly relatively low [12], and organic solvents could be remained using a templating agent [13]. Therefore, it might be the preferred choice for preparing PCPs by using a suitable pore-foaming agent. The pore-foaming agents are usually the substances that produce gas when exposed to heat, such as ammonium bicarbonate (NH4HCO3) and sodium bicarbonate (NaHCO3) [14]. In our early reports, hydroxypropyl methylcellulose (HPMC E3) and polyvinylpyrrolidone (PVP K30) exhibited great potential in improving the flowability and compactibility of APIs [7]. Hence, NH4HCO3 and NaHCO3 were utilized as the pore-foaming agents; meanwhile, HPMC E3 and PVP K30 were utilized as the shell materials.
Faecal microbiota transfer in patients with microscopic colitis – a pilot study in collagenous colitis
Published in Scandinavian Journal of Gastroenterology, 2020
Savanne Holster, Julia Rode, Johan Bohr, Ashok Kumar Kumawat, Gábor Veress, Elisabeth Hultgren Hörnquist, Robert Jan Brummer, Julia König
Ten patients were included in the study (Table 3). All patients were female and between 44 and 70 years of age. If using budesonide before the start of the study, this was discontinued at least 11 days before the baseline visit. In nine of the ten patients, the CC diagnosis was confirmed by histopathology of the biopsies collected from the ascending colon and right flexure during the whole colonoscopy for the first FMT. In one patient, an earlier histology-based CC diagnosis could not be confirmed, although the inclusion criteria (based on symptoms assessed by interview) were fulfilled. The results of this patient were excluded from the analyses. Three of the nine remaining patients had co-morbid autoimmune or chronic inflammatory disease. Table 4 shows the concomitant medications of the patients which were kept stable until after the 12-week visit. In addition, four patients occasionally took loperamide and one patient occasionally took simeticone (an anti-foaming agent) during the course of the study. Three patients were current smokers, five patients had smoked in the past and one patient had never smoked. One patient was lost to follow-up after the six-week visit for unknown reasons. Two patients started with budesonide between eight and twelve weeks, both as they were not content with the effect of the FMT treatment. No dietary changes were reported.
Multidisciplinary management and outcome in pancreatic cancer patients treated with high-intensity focused ultrasound
Published in International Journal of Hyperthermia, 2020
Marcus Thudium, Birgit Bette, Tolga Tonguc, Shiwa Ghaei, Rupert Conrad, Marc U. Becher, Martin Mücke, Guido Luechters, Holger Strunk, Milka Marinova
Pretreatment evaluation included medical history, physical examination and laboratory tests. Due to the lesion proximity to some parts of the gastrointestinal tract, e.g., stomach and duodenum, a specific bowel preparation similar to that prior to coloscopy is required to avoid possible complications. The bowel preparation starts one day before the procedure and consists of liquid food, no gas producing food, fasting for 12 h, and use of laxatives. On the treatment day, a stomach tube is placed to apply anti-foaming agents (e.g., simethicone) binding residual air bubbles in the stomach and bowel. The skin of the patient´s upper abdominal wall is shaved, degreased and degassed.